Advertisement
Screener

Cardio Diagnostics Holdings, Inc. (CDIO) Expense Breakdown

Cardio Diagnostics Holdings, Inc. Expense Breakdown

No Expense Breakdown for CDIO on this site yet.

  • 2026-06-30: Reportable segment operating $5.59K.
  • 2025-06-30: Reportable segment operating $8.48K.

Source checked: the stored Expense Breakdown page for CDIO.

Expenses by product

Depreciation, Depletion and Amortization, Nonproduction: each quarter (3 month)

Quarter endReportable segment operating
2026-06-30$5.59K
2025-06-30$8.48K

Operating expenses: each quarter (3 month)

Quarter endReportable segment operating
2026-06-30$1.50M
2025-06-30$1.69M

Research and development: each quarter (3 month)

Quarter endReportable segment operating
2026-06-30$162.93K
2025-06-30$178.54K

Selling and Marketing Expense: each quarter (3 month)

Quarter endReportable segment operating
2026-06-30$190.18K
2025-06-30$202.85K

Similar stocks

Stock NameCountryMarket CapPE Ratio
VOLITIONRX LTD (VNRX)$0.003B-0.64
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92